PFKFB3 and age-related macular degeneration: Whereas microglia are highly glycolytic and inflammatory agent secretors, Wang et al.‘s study revealed that targeted knockdown of PFKFB3 inhibited amyloid β (Aβ)-mediated microglial activation, leading to inflammation and RPE damage [91], adding a strategy for the treatment of AMD.